Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular monitor, the Fidelity 100.
The Fidelity 100 is a patient module that wirelessly transmits the ECG to a data collection device (laptop), which reportedly can store up to 2500 hours of data. During patient evaluation, a physician can mark events of interest. After the ECG procedure, marked events can be quickly evaluated and data can be stored to flash memory for future evaluation, said the company.
For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...
June 16, 2026 
June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...
June 05, 2026 
June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...
June 02, 2026 
May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...
May 08, 2026 
April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...
April 15, 2026 
March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...
March 06, 2026 
March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
March 04, 2026 
Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...
February 24, 2026 
Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...
February 20, 2026 
Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...
February 16, 2026 